Orange G

Orange G

SCHEMBL17279088

O=S(=O)(O)c1cc(S(=O)(=O)O)c2c(/N=N\c3ccccc3)c(O)ccc2c1

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 1/20 0.70
▸ MAPK1 P28482 3/20 0.69
▸ ALDH1A1 P00352 1/20 0.69
▸ SUMO2 P61956 1/20 0.62
▸ SUMO1 P63165 1/20 0.62
▸ SENP7 Q9BQF6 1/20 0.62
▸ SENP2 Q9HC62 1/20 0.62
▸ PHLPP2 Q6ZVD8 1/20 0.56
▸ PRMT1 Q99873 1/20 0.54
▸ MAPT P10636 2/20 0.54
▸ KMT2A Q03164 2/20 0.54
▸ GAA P10253 1/20 0.54
▸ TDP1 Q9NUW8 1/20 0.54
▸ CYP1A2 P05177 4/20 0.53
▸ CYP2C9 P11712 3/20 0.53
▸ TSHR P16473 1/20 0.48
▸ PTPRA P18433 1/20 0.48
▸ PTPRB P23467 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ HIF1A Q16665 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Orange G SCHEMBL3020776 1.00 APP (0.70) APPMAPK1ALDH1A1SUMO2SUMO1
Orange G SCHEMBL31621938 1.00 APP (0.70) APPMAPK1ALDH1A1SUMO2SUMO1
Orange G SCHEMBL29388415 1.00 APP (0.70) APPMAPK1ALDH1A1SUMO2SUMO1
Orange G SCHEMBL3873347 1.00 APP (0.70) APPMAPK1ALDH1A1SUMO2SUMO1
Orange G SCHEMBL3020774 1.00 APP (0.70) APPMAPK1ALDH1A1SUMO2SUMO1
Orange G SCHEMBL6051005 0.99 APP (0.69) APPMAPK1ALDH1A1SUMO2SUMO1
SCHEMBL1098585 0.99 APP (0.69) APPMAPK1ALDH1A1SUMO2SUMO1
Orange G SCHEMBL17312267 0.99 APP (0.69) APPMAPK1ALDH1A1SUMO2SUMO1
SCHEMBL110351 0.99 APP (0.69) APPMAPK1ALDH1A1SUMO2SUMO1
SCHEMBL461768 0.99 APP (0.69) APPMAPK1ALDH1A1SUMO2SUMO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190033319-A1 BINDING DOMAIN MAPPING George Mason Research Foundation, Inc. (US) 2019-01-31 — — US disclosed
US-20150338417-A1 BINDING DOMAIN MAPPING GEORGE MASON UNIVERSITY 2015-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190033319-A1 BINDING DOMAIN MAPPING SNRPE, HSPBP1, CNBP APP 3935/4885MAPK1 1907/4885ALDH1A1 4794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback